NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/19/2023
Back to search
Official data from USPTO
COVIDEZE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
12/19/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
09/14/2021
Registration date
12/19/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2023
Last transaction
12/19/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/31/2022
First use in commerce
11/07/2022
Drawing code
3
Owner type
03
Owner location
Cleveland, MS, US
Examiner
LINCOSKI JR, JOHN T
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "COVIDEZE" in a stylized font in the color white, outlined in a white hexagon shape, all against a blue background.
Holders and representatives
Holders
B&W PHARMACEUTICALS INC.
Representatives
B&W PHARMACEUTICALS INC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pain relief medication for the treatment of coronavirus symptoms
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/14/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/13/2023
DOCK
ASSIGNED TO EXAMINER
11/13/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/08/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/08/2022
IUAF
USE AMENDMENT FILED
11/18/2022
EISU
TEAS STATEMENT OF USE RECEIVED
11/18/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/24/2022
ALIE
ASSIGNED TO LIE
03/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/15/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/15/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/15/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/15/2022
DOCK
ASSIGNED TO EXAMINER
03/09/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/20/2021
NWAP
NEW APPLICATION ENTERED
09/17/2021
Continuous trademark protection
Get notified about every new filing that threatens COVIDEZE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.